NDC 64038-139 - Cyclo/Mag 10mg/200mg
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 64038-139
- Package NDCs from labels
- 64038-139-60
- Manufacturer
- Living Well Pharmacy, Inc. | Apotheca Supply | Spectrum Laboratory Products, Inc.
- Effective date
- 2010-02-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CYCLO/MAG KIT | Living Well Pharmacy, Inc. | Apotheca Supply | Spectrum Laboratory Products, Inc. | 2010-02-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64038-139-60 | Cyclo/Mag 10mg/200mg | 60 g in 1 BOTTLE | POWDER | 60 g | 1 g in 1g | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CYCLOBENZAPRINE HYDROCHLORIDE | ACTIVE INGREDIENT | 0VE05JYS2P | CYCLO/MAG 10MG/200MG (CYCLOBENZAPRINE HYDROCHLORIDE, MAGNESIUM OXIDE) KIT [LIVING WELL PHARMACY, INC.] | 1 | |
| MAGNESIUM OXIDE | ACTIVE INGREDIENT | 3A3U0GI71G | CYCLO/MAG 10MG/200MG (CYCLOBENZAPRINE HYDROCHLORIDE, MAGNESIUM OXIDE) KIT [LIVING WELL PHARMACY, INC.] | 1 | |
| CYCLOBENZAPRINE | ACTIVE MOIETY | 69O5WQQ5TI | CYCLO/MAG 10MG/200MG (CYCLOBENZAPRINE HYDROCHLORIDE, MAGNESIUM OXIDE) KIT [LIVING WELL PHARMACY, INC.] | 1 | |
| MAGNESIUM OXIDE | ACTIVE MOIETY | 3A3U0GI71G | CYCLO/MAG 10MG/200MG (CYCLOBENZAPRINE HYDROCHLORIDE, MAGNESIUM OXIDE) KIT [LIVING WELL PHARMACY, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cyclobenzaprine hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 348c7ad4-b380-4b78-88f4-106b94079f52 | 2026-04-01 | Warnings, Adverse reactions | 0VE05JYS2P |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | e4e8bab3-c5e7-4d2b-9692-ee6c6799b120 | 2026-04-01 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 014dd648-5b84-4d1d-80fc-a467e2d741ef | 2026-04-01 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | ac8ae965-af50-41d3-8df5-ca6daf4bbd1c | 2026-04-01 | Warnings, Adverse reactions | 0VE05JYS2P |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | e343fd12-1ca2-418a-b690-f3e8f567596d | 2026-04-01 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 29ca9548-23b0-4c50-82cb-4f0564d7e065 | 2026-04-01 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Preferred Pharmaceuticals, Inc. | a4cc7965-2ba8-42e8-8c5c-b90145a6598a | 2026-04-01 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | REMEDYREPACK INC. | fada6577-bcb8-422c-be37-08562919ebc9 | 2026-03-30 | Warnings, Adverse reactions | 0VE05JYS2P |
| Magnesium Oxide | MAGNESIUM OXIDE | Bryant Ranch Prepack | f98cac25-63f2-478e-b785-20cba1c56565 | 2026-03-27 | Warnings | 3A3U0GI71G |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 96b650d8-4ad5-42af-aa8c-aa0ac25abfb5 | 2026-03-17 | Warnings, Adverse reactions | 0VE05JYS2P |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | DirectRx | cdc5b438-6b6b-0cdd-e053-2a95a90a7f75 | 2026-03-06 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Direct_Rx | 15aad4af-5c05-be36-e063-6294a90a9bb3 | 2026-03-05 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 4c3a3b4f-7b2b-3fe9-e063-6394a90aae47 | 2026-03-04 | Warnings, Adverse reactions | 0VE05JYS2P |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | Bryant Ranch Prepack | dc3cc6b6-c692-4986-8ff7-3a6cd8c85cb2 | 2026-03-04 | Warnings, Adverse reactions | 0VE05JYS2P |
| Folartex | MULTIVITAMIN | Oncora Pharma, LLC | 0a4cb0ab-565f-45e8-a989-740bccef21cd | 2026-02-25 | Warnings, Adverse reactions | 3A3U0GI71G |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | Asclemed USA, Inc. | 06da53af-5b46-4e32-a64c-9677e27ae229 | 2026-02-14 | Warnings, Adverse reactions | 0VE05JYS2P |
| Aflora | MULTIVITAMIN | Oncora Pharma, LLC | 38e463d1-f608-7cb5-e063-6294a90a4abb | 2026-02-12 | Warnings, Adverse reactions | 3A3U0GI71G |
| Folixia | MULTIVITAMIN | Oncora Pharma, LLC | 413945b5-116b-d8b6-e063-6394a90a55e8 | 2026-02-12 | Warnings, Adverse reactions | 3A3U0GI71G |
| Nutralyn | MULTIVITAMIN | Oncora Pharma, LLC | 33da017b-1e8c-d41c-e063-6394a90aab8c | 2026-02-12 | Warnings, Adverse reactions | 3A3U0GI71G |
| Folaten | MULTIVITAMIN | Oncora Pharma, LLC | 93086235-2c33-424d-b0c3-213031988581 | 2026-02-12 | Warnings, Adverse reactions | 3A3U0GI71G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.